Definitive Healthcare Corp. (DH) Reports In-Line Q4 EPS

Definitive Healthcare Corp. (NASDAQ: DH) reported Q4 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $46.3 million versus the consensus estimate of $44.62 million.

GUIDANCE:

Definitive Healthcare Corp. sees Q1 2022 EPS of $0.02-$0.04, versus the consensus of $0.05. Definitive Healthcare Corp. sees Q1 2022 revenue of $47-49 million, versus the consensus of $46.63 million.

Definitive Healthcare Corp. sees FY2022 EPS of $0.22-$0.26, versus the consensus of $0.26. Definitive Healthcare Corp. sees FY2022 revenue of $218-222 million, versus the consensus of $207.9 million.

For earnings history and earnings-related data on Definitive Healthcare Corp. (DH) click here.

You May Also Be Interested In

• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Arcos Dorados (ARCO) Tops Q2 EPS by 7c
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance